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DiabetesBackground: Therapy for certain medical conditions occurs in a stepwise fashion, where one medication
is recommended as initial therapy and other medications follow. Sequential pattern mining is a data
mining technique used to identify patterns of ordered events.
Objective: To determine whether sequential pattern mining is effective for identifying temporal relation-
ships between medications and accurately predicting the next medication likely to be prescribed for a
patient.
Design: We obtained claims data from Blue Cross Blue Shield of Texas for patients prescribed at least one
diabetes medication between 2008 and 2011, and divided these into a training set (90% of patients) and
test set (10% of patients). We applied the CSPADE algorithm to mine sequential patterns of diabetes
medication prescriptions both at the drug class and generic drug level and ranked them by the support
statistic. We then evaluated the accuracy of predictions made for which diabetes medication a patient
was likely to be prescribed next.
Results: We identiﬁed 161,497 patients who had been prescribed at least one diabetes medication. We
were able to mine stepwise patterns of pharmacological therapy that were consistent with guidelines.
Within three attempts, we were able to predict the medication prescribed for 90.0% of patients when
making predictions by drug class, and for 64.1% when making predictions at the generic drug level. These
results were stable under 10-fold cross validation, ranging from 89.1%–90.5% at the drug class level and
63.5–64.9% at the generic drug level. Using 1 or 2 items in the patient’s medication history led to more
accurate predictions than not using any history, but using the entire history was sometimes worse.
Conclusion: Sequential pattern mining is an effective technique to identify temporal relationships
between medications and can be used to predict next steps in a patient’s medication regimen. Accurate
predictions can be made without using the patient’s entire medication history.
 2014 Elsevier Inc. All rights reserved.1. Introduction
The healthcare system has made considerable headway in the
process of transitioning from paper charts to the electronic health
record (EHR). This transition has led to the accumulation of vast
amounts of data stored in clinical data warehouses which can be
used to add to clinical knowledge and guide decision support sys-
tems. Data mining is the process of discovering hidden knowledge
within a large information repository, and data mining techniques
developed for use in retail or other industries can be applied
to healthcare [1]. Sequential pattern mining is a data miningtechnique used to identify patterns of ordered events [2]. In this
paper, we use sequential pattern mining to automatically infer
temporal relationships between medications, visualize these
relationships, and generate rules to predict the next medication
likely to be prescribed for a patient.
2. Background
2.1. Stepwise pharmacological therapy
Stepwise pharmacological therapy for management of diseases
is common in medicine for progressive conditions such as diabetes
mellitus. For example, the American Diabetes Association recom-
mends a treatment algorithm according to progression of disease
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tions and metformin, adds a sulfonylurea if metformin doesn’t pro-
vide adequate glucose control, then basal insulin, and eventually
progresses to using intensive insulin [3]. The algorithm also
includes a second tier of less well-validated therapies that instead
adds pioglitazone or a GLP-1 agonist to initial lifestyle interven-
tions and metformin, and then may add a sulfonylurea or basal
insulin before progressing to more intensive insulin therapy. One
can imagine a clinical decision support system that determines
where a patient lies within this stepwise algorithm and makes
appropriate suggestions to the physician. However, advances in
clinical decision support rely on an accurate knowledge base [4].
For example, indication-based prescribing and summarization
both rely on a knowledge base of relationships between medica-
tions and diagnoses [5–8]. Development and maintenance of an
accurate knowledge base by experts is time consuming and expen-
sive. In our past work, we have used frequent item set and associ-
ation rule mining to infer relationships between medications,
laboratory results, and problems [5,9,10]. However, these data
mining techniques do not capture temporal information. Little
work has been done on the automated development of a knowl-
edge base of temporal relationships between medications, which
could be used to guide clinical decision support based around drug
regimen changes.
2.2. Sequential pattern mining
Sequential pattern mining is a data mining technique used to
identify patterns of ordered events within a database. First intro-
duced in 1995 by Rakesh Agrawal of IBM’s Almaden Research Cen-
ter [11], its original applications were in the retail industry where
it can be used to predict that within a certain time period after pur-
chasing a certain book, a customer is likely to purchase its sequel.
Applications in medicine were proposed early on [2] and eventu-
ally manifested in disease susceptibility prediction [12,13], read-
mission [14], and pharmacovigilance [15,16].
2.3. SPADE
Identifying all frequent sequential patterns in a transaction
database, especially in large databases such as those found in
healthcare requires an efﬁcient algorithm to deal with the large
search space, and a number of different algorithms have been
developed. For example, in a database with 100 different items
and sequences up to 5 items long (with item repeats allowed),
there would be over a billion potential sequential patterns. In
2001, Zaki described an algorithm called SPADE (Sequential Pat-
tern Discovery using Equivalence classes), which uses a number
of strategies to make sequential pattern mining more efﬁcient
[17]. Sequential pattern mining typically starts with a transaction
database, where each transaction has three ﬁelds: the ‘‘sequence-
id’’ corresponding to the subject of the sequence (e.g. customer’s
frequent shopper number or patient’s medical record number);
the ‘‘transaction-time’’; and the items associated with the transac-
tion (Table 1). Like previous algorithms, SPADE starts with the hor-
izontal database layout like that seen in Table 1, but it thenTable 1
Example of transaction database.
Sequence-id Transaction-time Items
Patient_1 Aug-2-2008 (metformin, simvastatin, venlafaxine)
Patient_1 Nov-3-2008 (aspirin, glipizide)
Patient_1 July-1-2009 (hydrochlorothiazide, insulin)
Patient_2 Dec-3-2008 (aspirin, azithromycin, metformin)
Patient_2 Aug-5-2009 (insulin)transforms the dataset into vertical ‘‘id-lists’’ for each item, each
consisting of all the sequence-ids and transaction-times where
the item is found. Storage of the vertical id-lists allows sequential
patterns to be found using intersections of id-lists. For example,
the sequential pattern (metformin, insulin) could be found using
the intersection of id-lists for the two items. This method mini-
mizes the number of database scans that are required. SPADE also
makes use of common preﬁxes between sequences to decrease the
memory requirement. cSPADE is a version of SPADE which incor-
porates constraints on sequences, such as lengths or time window
[18]. It has been applied in protein folding [19], hepatitis classiﬁca-
tion [20], insider trading detection [21], and satellite image pro-
cessing [22]. The R package ‘arulesSequences’ provides an
interface to the c++ version of cSPADE [23].
Recently, Sun et al. [24] used sequential pattern mining to
discover common two-item patterns in outpatient data for patients
with diabetes; however no study that we know of has used
sequential pattern mining to make predictions about next
medications likely to be prescribed.
In this paper, we describe the use of cSPADE to identify tempo-
ral patterns of medications prescribed for diabetes. We infer tem-
poral relationships from these mined patterns which we visualize
in digraphs. We then use the knowledge base of mined patterns
to generate rules which predict the next diabetes medication pre-
scribed for a test set of patients.
2.4. Hypothesis
We hypothesize that sequential pattern mining is an effective
technique to identify temporal relationships between medications
and generate rules that predict which diabetes medication is pre-
scribed next for a patient.3. Methods
3.1. Deﬁnitions
In formal terms, let I = {i1, i2, . . ., im} be an item set , for example
(metformin, simvastatin, venlafaxine). Let sequence s, denoted by
hs1, s2, . . ., sni be a temporally ordered list of item sets, for
example h(metformin, simvastatin, venlafaxine), (aspirin, glipiz-
ide), (hydrochlorothiazide, insulin)i. Let a be another sequence
denoted h(metformin), (glipizide) ,(insulin)i. Sequence a is called
a subsequence of sequence s since (metformin) # (metformin,
simvastatin, venlafaxine) and (aspirin) # (aspirin, glipizide) and
(insulin) # (hydrochlorothiazide, insulin). A data-sequence is a list
of transactions with the same sequence-id (i.e., all transactions
belonging to one patient.) The support of sequence a is the fraction
of data-sequences which contain a as subsequence. For example,
both data-sequences in Table 1 contain the sequence (metformin,
insulin) but only 1 out of 2 contains the sequence (metformin, gli-
pizide, insulin) so if this were the complete dataset, the support of
(metformin, insulin) would be 1 and the support of (metformin,
glipizide, insulin) would be 0.5. The task of sequential pattern min-
ing is to identify frequent sequences, where frequent is deﬁned as
having support above a user-deﬁned threshold. In this paper, we
will refer to frequent sequences mined from data-sequences as
mined sequential patterns, and we will refer to a patient’s
data-sequence (the temporally-ordered history of all medication
prescribed for that patient) as a patient sequence.
3.2. Dataset
We used the dataset described in Parikh et al. [25,26], consist-
ing of inpatient claims data for 6,486,226 members of Blue Cross
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ance provider in Texas. We extracted a record of all medications
prescribed between 2008 and 2011. We included in our study all
patients who were prescribed at least one diabetes medication.
We then divided the group of patients into a training set (90% of
patients) from which to generate rules and a test set (10% of
patients) to make predictions for.3.3. Preparation for data mining
Our ﬁrst task was to determine the granularity at which we
would mine the data (e.g., the drug class, generic drug name only,
generic drug and dose, or brand name and dose) since sequential
pattern mining can generate a vast number of mined patterns.
We decided to mine the data at two different levels of granularity:
ﬁrst at the class level and then at the generic drug level. Our classes
were based on World Health Organization Anatomic Therapeutic
Chemical (ATC) classes: biguanide, sulfonylurea, insulin, PPAR ago-
nist, DPP-4 inhibitory, GLP-1 agonist, meglitinide, bromocriptine,
amylin analog, and alpha-glucosidase inhibitor (Table 2). For min-
ing at the generic drug level, we identiﬁed 37 different generic
drugs including various 2-ingredient combinations, usually met-
formin and one additional oral antihyperglycemic ingredient. We
treated each ingredient combination as a unique generic drug.
We created a mapping table for generic diabetes drugs and another
for diabetes drug classes. These tables link each patient’s prescrip-
tion to a generic drug and drug class.3.4. Sequential pattern mining process
Our sequential pattern mining process is shown in Fig. 1. We
performed this process twice; once at the class and once at the
generic drug level. We started with a pre-existing database resid-
ing in the Microsoft SQL Server relational database management
system. We loaded the mapping table into SQL and performed a
SQL query to organize the data into the horizontal transaction
format required by the algorithm (similar to Table 1). Because
we wanted to identify changes in the medication regimen rather
than patterns of renewals, we selected only the ﬁrst prescription
of a medication for a patient. For example, if a patient was pre-
scribed metformin, then a glipizide, then had their glipizide
renewed, and then was switched to glyburide, their sequence
at the class level would be (biguanide, sulfonylurea) and their
sequence at the generic drug level would be (metformin, glipiz-
ide, glyburide). We used the R package ‘arulesSequences’ to mine
the data for frequent patterns using a support of 1e-10. We
chose this very small support to capture a large set of patterns,
which we later sorted by the support statistic to identify the
most relevant patterns.Table 2
Mapping of diabetes drugs to classes.
Drug class Generic drug
Alpha-glucosidase inhibitor Acarbose, Miglitol, Voglibose
Amylin analog Pramlintide
Biguanide Metformin
Bromocriptine Bromocriptine
DPP-4 inhibitor Alogliptin, Anagliptin, Gemigliptin
GLP-1 agonist Exenatide, Liraglutide, Lixisenatide
Insulin Insulin lispro, Insulin aspart, Insul
Meglitinide Nateglinide, Repaglinide, Mitiglini
PPAR agonist Pioglitazone, Rosiglitazone
Sulfonylurea Acetohexamide, Carbutamide, Chlo
Glipizide, Gliquidone, Glisoxepide,3.5. Visualization
We took the mined patterns output by R from the training set at
the class level, grouped them by length, and ranked them by sup-
port to determine the top sequential patterns. We also used Graph-
viz [27] to generate a digraph of the 2-item sequences. To make the
visualization clearer, we added virtual start and end nodes to each
patient’s medication sequence before running the sequential pat-
tern mining algorithms to highlight common initiation and termi-
nation points, and also pooled data from the training and test sets.
3.6. Evaluation
We set out to explore two research questions: (1) whether
sequential pattern mining is useful for predicting changes to a
patient’s medication regimen and (2) how useful the patient’s his-
tory of prior medication changes is when making a prediction.
To investigate the ﬁrst research question, we started with the R
output of sequential patterns mined from the training set. To gen-
erate prediction rules, we transformed each mined pattern into an
antecedent–consequent pair, using the last item of the pattern as
the consequent, and all prior items as the antecedent. An example
is shown in Fig. 2. Each antecedent–consequent pair served as a
rule which, given the antecedent, predicted the consequent.
To prepare the test set for the evaluation, we transformed each
patient’s sequence into a base stem with an associated ‘‘next drug’’
(Fig. 2). The base stem represents the history of the patient’s diabe-
tes medication changes prior to their most recent diabetes pre-
scription. In the special case where a patient had only a single
diabetes drug, we used an empty base stem and the patient’s only
drug as their next drug. To predict the patient’s next drug, we
looked for rules whose antecedent matched the base stem, ranked
them by support, and used the top 5 consequents as predictions for
that patient’s next drug. We determined how our success changed
as we varied how many of the top 5 predictions we included for
each patient, with each counting as 1 ‘‘prediction attempt’’. In
cases where we were not able to make 5 predictions from a stem,
we fell back on predictions made from shorter stems. For example,
if we had no rule for a base stem, ‘‘Meglitinide? Biguanide? Sul-
fonylurea? DPP-4 inhibitor’’, we would use the rule for ‘‘Bigua-
nide? Sulfonylurea? DPP-4 inhibitor’’.
To investigate the second research question, we varied the
amount of the base stem used to make our prediction by iteratively
truncated each base stem, removing one item at a time from the
beginning of the stem. We determined how often the next drug
could be correctly predicted within the ﬁrst three prediction
attempts, theorizing that three suggestions would be a reasonable
number to display in the EHR. To assess the stability of our results,
we used 10-fold cross validation to re-estimate the number of
patients for whom the next drug could be correctly predicted
within three prediction attempts., Linagliptin, Saxagliptin, Sitagliptin, Teneligliptin, Vildagliptin
in glulisine, Regular insulin, Insulin glargine, Insulin detemir, NPH insulin
de
rpropamide, Metahexamide, Tolbutamide, Tolazamide, Glyburide, Glibornuride,
Glyclopyramide, Glimepiride, Gliclazide
Fig. 1. Pipeline of sequential pattern mining process.
Fig. 2. Evaluation example. Mined patterns from training data are transformed into rules which are used to predict the next drug, given base stems derived from patient
sequences in the test set.
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generic drug level. Given the design of our evaluation, we excluded
patients with more than one prescription initiated during the same
transaction.
4. Results
4.1. Dataset statistics
We identiﬁed 161,497 patients prescribed at least one diabetes
medication and divided them into a training set (n = 145,936) and
test set (n = 16,011). The most frequent mined sequential patternsfor diabetes medication classes are shown in Table 3. Of the top
patterns of length 2–6 items, 87% (13/15) begin with a biguanide,
47% (7/15) have a sulfonylurea as the second item, and 67% (10/
15) end with insulin. We visualized the top 2-item sequential pat-
terns in a digraph in Fig. 3. Thicker edges between nodes denote a
pattern of higher support. The digraph shows a stepwise progres-
sion that begins with a biguanide, and either stops there or pro-
gresses to a sulfonylurea and/or other non-insulin diabetes
medications, and afterwards, may continue on to insulin. Insulin
is typically the ﬁnal step in regimens that have progressed through
multiple drugs, as evidenced by the many arrows going from other
medications that terminate on insulin.
Table 3
Most frequent mined sequential patterns for diabetes medications, by class.
Sequential pattern Support
2-item sequential patterns
Biguanide? Sulfonylurea 0.09308
Biguanide? Insulin 0.07321
Biguanide? DPP-4 inhibitor 0.07261
3-item sequential patterns
Biguanide? Sulfonylurea? Insulin 0.01089
Biguanide? Sulfonylurea? DPP-4 inhibitor 0.01002
Biguanide? DPP-4 inhibitor? Insulin 0.00858
4-item sequential patterns
Biguanide? Sulfonylurea? DPP-4 inhibitor? Insulin 0.00127
Biguanide? PPAR agonist? DPP-4 inhibitor? Insulin 0.00123
Sulfonylurea? Biguanide? DPP-4 inhibitor? Insulin 0.00103
5-item sequential patterns
Biguanide? Sulfonylurea? PPAR agonist? DPP-4
inhibitor? Insulin
0.00013
Biguanide? Sulfonylurea? DPP-4 inhibitor? GLP-1
agonist? Insulin
0.00012
Biguanide? Sulfonylurea? DPP-4 inhibitor? Insulin? GLP-1
agonist
0.00012
6-item sequential patterns
Biguanide? PPAR agonist? DPP-4 inhibitor? Insulin? GLP-1
agonist? Sulfonylurea
0.00002
Sulfonylurea? Biguanide? DPP-4 inhibitor? PPAR
agonist? GLP-1 agonist? Insulin
0.00002
Biguanide? PPAR agonist? Sulfonylurea? DPP-4
inhibitor? GLP-1 agonist? Insulin
0.00002
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After excluding patients with more than one drug class initiated
during the same transaction, we were left with 121,584 patients in
our training set and 11,664 patients in our test set. We were able to
correctly guess the next class of diabetes medication prescribed for
6943 (59.5%) of patients using one attempt, and this number
increased with successive attempts, so that 10,493 (90.0%) had a
correct prediction when 3 attempts were made, and 11,401
(97.7%) when 5 attempts were made (Fig. 4). The majority of
patients (67.8%) had a sequence with only one item (i.e., they wereFig. 3. Digraph of diabetes medications. The most frequent 2-item sequences are show
direction between nodes with highest support are shown; reverse directions with lesseprescribed only one class of diabetes medication within the study
period), and thus had an empty base stem (Table 4). We were able
to make a correct prediction of the medication prescribed for 92.7%
of these patients within three attempts. Overall, accuracy ranged
from 79.6% to 100.0% when no base stem was used to make a pre-
diction, even for patients with a non-empty base stem. For patients
with at least one drug class in their base stem, using a 1-length
truncated stem to predict the next drug class was always better
than or equal than using the 0-length truncated stem. Using a
2-length stem led to more accurate predictions only for patients
with 2 drug classes in their base stem and using 3, 4, or 5-length
stems to make a prediction was always worse than or equal to
using a 1 or 2-length stem.
4.3. Evaluation at generic drug level
After excluding patients with more than one prescription initi-
ated during the same transaction, we were left with 117,641
patients in our training set and 12,897 patients in our test set.
We were able to make a correct prediction for 6637 patients
(51.5%) using one attempt, 8270 (64.1%) with three attempts, and
9270 (71.9%) with ﬁve attempts (Fig. 4). We were able to correctly
predict the next prescribed drug within 3 attempts for 71.4% of the
7778 patients with a 0-length base stem (Table 5). For patients
with a base stem containing at least one drug, we were able to
correctly predict the next prescribed drug within three attempts
32.6–45.4% of the time without using any portion of their base
stem. Accuracy increased when using 1 item from the base stem,
and increased further when using 2 items, except in cases where
the base stem was 5 items long. Using base stems more than 2
items long was always worse than using 2-length base stems.
Overall, the best predictions were made when using 1–2 items
from the patient’s base stem.
4.4. Cross validation
Under 10-fold cross validation at the drug class level, the
percentage of patients with a correct prediction made within 3n. Differences in support are represented by edge thickness. For clarity, only the
r support are suppressed.
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the generic drug level, this percentage ranged from 63.5% to 64.9%,
with an average 64.1%.5. Discussion
We were able to demonstrate the effectiveness of sequential
pattern mining to identify temporal relationships between
diabetes medications and reconstruct a stepwise usage pattern
that resembles recommendations. Using sequential pattern min-
ing, we were also able predict the next medication likely to be
prescribed for a patient.
Table 3 shows a progression of medications that, overall, is con-
sistent with recommendations made by the American Diabetes
Association [3], i.e., start with a biguanide, add a sulfonylurea,
and progress to basal insulin. In fact, the 3-item mined sequential
pattern with the highest support was ‘‘Biguanide? Sulfonyl-
urea? Insulin’’. The addition of a DPP-4 inhibitor or other oral
antihyperglycemic to a biguanide was also common but had lower
support. This mirrors the American Diabetes Association’s algo-
rithm’s second tier of less well-validated therapies, which adds
pioglitazone or a GLP-1 agonist to initial lifestyle medications
and metformin.
While complex, Fig. 3 also reveals clear temporal directions
between diabetes drugs consistent with recommendations. For
example, there is a clear preference demonstrated for starting a
patient on a biguanide before other medications. The second most
frequent initial medication is a sulfonylurea. According to guide-
lines, a sulfonylurea is an acceptable initial medication for patients
who have a contraindication to a biguanide (e.g., chronic kidney
disease). In the digraph, the nodes for biguanides and sulfonylureas
have edges directed towards DPP-4 inhibitors, PPAR-agonists, and
GLP-1 agonists, consistent with the American Diabetes Associa-
tions description of these as less well-validated therapies. Many
pathways converged on insulin, which is consistent with its use
in patients with type II diabetes with inadequate glucose control
on other medications.
5.1. Evaluation
Using three attempts, we were able to predict the medication
prescribed for 90.0% of patients when making predictions by drug
class, and for 64.1% when making predictions at the generic drug
level. These numbers were very stable under cross validation, with
a range of less than 2%. This supports the idea that sequential pat-
tern mining could be useful for predicting which class of medica-
tions a prescriber might choose next when treating a progressive
disease like diabetes. This prediction could be used to suggest next
medications in an EHR when a provider was reviewing medications0%
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Fig. 4. Accuracy of predictions for next diabetes medication. The percentage of
sequences with a correct prediction made is shown for base stems by drug class
(dark line) and drug (dotted line).for a particular problem (Fig. 5). Suggesting more than one medica-
tion would increase the accuracy of the prediction, as demon-
strated in Fig. 4.
Performance of the predictions was better at the class level than
at the drug level (Fig. 4). Predicting the next drug was a more dif-
ﬁcult task since there were 38 possible drugs to predict from, as
opposed to 10 possible drug classes. When predicting the next
drug class prescribed for a patient whose base stem contained 3
items, there were only 7 remaining drug classes to choose from,
so that using 5 attempts it was possible to cover 71% of the remain-
ing drugs. In comparison, when making predictions at the drug
rather than drug class level, 5 attempts for a patient with a base
stem of 3 items would only cover 9% of all remaining drugs.
When a patient had no drugs in their base stem, i.e., was being
started on his or her ﬁrst diabetes medication, we were able to
make a very accurate prediction (92.7% at the drug class level
and 71.4% at the generic drug level using three attempts). This
accuracy was better than when a patient had a pre-existing
medication regimen.
Accuracy was surprisingly high when the patient’s base stem
was not used to make a prediction, especially when making predic-
tions at the drug class level. Using 1 or 2 items in the patient’s base
stem led to more accurate predictions, but it was not always better
to use the patient’s entire base stem, i.e. their entire medication
history, and sometimes was worse (Tables 4 and 5). This suggests
that doctors may not be conditioning their prescribing behaviors
based on the patient’s entire medication history. Overall, these
results support the idea that sequential pattern mining would be
useful for making suggestions in the EHR about which diabetes
medication to prescribe next, and accurate predictions could be
made without using all of the patient’s medication history.
5.2. Applications of the knowledge generated
Sequential pattern mining to identify temporal relationships
between medications has applications in clinical decision support
when a clinician is reviewing a patient’s medication regimen and
considering changing it. Guidelines could be made available within
the medical record; however, it is expensive and time-consuming
to maintain links to the most relevant guidelines in the right place
within the medical record. Sequential pattern mining is automated
and could guide algorithms that make suggestions when a provider
is changing a medication regimen. In Fig. 5 we demonstrate an
example for how suggestions for which medication to prescribe
next could be incorporated into a patient’s problem list. The bene-
ﬁts of having an automatically updated knowledge base of tempo-
ral relationships between medications include not only the
information provided to the physician (i.e., which medication to
prescribe next), but also the convenient placement of the right
links to the right medications at the right time, which could save
time for users.
The digraphs we created display interesting visual representa-
tions of stepwise medical therapy which could be of interest to
physicians planning a patient’s treatment regimen, as well as
patients who wish to understand a typical progression of medica-
tions used to treat their condition. These visualizations may also be
of use epidemiologically for those who wish to monitor and study
the behavior of prescribers at their institution. For example, the
typical treatment paths could be mined for different date ranges
in order to assess how quickly prescribers are modifying their
behavior to adhere to new guidelines.
5.3. Limitations
Since our dataset only captures claims ﬁled between 2008
and 2011, it is likely that some patients were started on other
Table 4
Accuracy of predictions for next diabetes drug class, by sequence base stem and number of previous prescriptions used to make prediction.
No. of drug classes in base stem No. of patients Percent with correct prediction made within three attempts, by length of stem utilized
0 (%) 1 (%) 2 (%) 3 (%) 4 (%) 5 (%)
0 7906 92.7
1 2475 79.6 81.1
2 903 86.4 87.2 88.2
3 280 95.7 95.7 95.4 94.6
4 82 92.7 97.6 97.6 93.9 93.9
5 18 100.0 100.0 100.0 100.0 100.0 100.0
Table 5
Accuracy of predictions of next diabetes drug, by sequence base stem and number of previous prescriptions used to make prediction.
No. of drugs in base stem No. of patients Percent with correct prediction made within three attempts, by length of stem utilized
0 (%) 1 (%) 2 (%) 3 (%) 4 (%) 5 (%)
0 7778 71.4
1 3082 45.4 58.8
2 1230 39.8 46.0 48.2
3 513 33.9 42.9 46.8 38.8
4 179 33.5 51.4 52.0 39.1 38.0
5 86 32.6 52.3 47.7 44.2 40.7 40.7
Fig. 5. Medication prediction use case. An example of how predictions for next medication for a disease might be incorporated into the problem list within an electronic
medical record.
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that patients who appear to have been started initially on insulin
were actually initiated on metformin and/or other medications
prior to the study period. Further, our dataset only spans 3 years,
while progression of diseases such as diabetes can take decades.
However, by assembling frequent 2-item sequences into a compre-
hensive digraph, we were able to visualize temporal relationships
between all diabetes medications. In addition, since our database
consists of claims data, all patients were insured, and the ﬁndings
might not apply to uninsured populations.
5.4. Future directions
We aim to explore further methods for using sequential pattern
mining to make accurate predictions about which medication a
prescriber will choose next, including training rules at the provider
level. We also aim to enhance our predictions by using a hybrid
model which incorporates not only sequential pattern mining,
but also additional proﬁle and clinical data including patient age,
gender, comorbidities, and laboratory results into predictions. For
example, knowing that a patient has chronic kidney disease would
inform which diabetes medication is initially suggested. Once we
have further developed this technique, we aim to evaluate theuse of sequential pattern mining to make predictions for treatment
with antidepressants, antibiotics, chemotherapy, and asthma
medications. We also aim to further develop the use of sequential
pattern mining to identify and incorporate useful temporal pat-
terns for clinical decision support applications in the EHR.6. Conclusion
Sequential pattern mining is a useful data mining technique for
identifying temporal relationships between medications. From
simple two-item sequences, drug regimen pathways can be visual-
ized that ﬁt with guidelines for stepwise drug therapy. These tem-
poral relationships are useful for making predictions about which
medication a prescriber is likely to choose next when treating a
progressive disease such as diabetes. Future work is necessary to
optimize the use of sequential pattern mining to detect temporal
relationships among items in the medical record and improve
patient care.
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